To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

NCT01904110 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Risedronate/Cholecalciferol combination(montly)
DRUG: Risedronate/Cholecalciferol combination(weekly)

Sponsor

Hanlim Pharm. Co., Ltd.